Elaine Chiquette

Summary

Affiliation: Amylin Pharmaceuticals
Country: USA

Publications

  1. pmc Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
    Elaine Chiquette
    Amylin Pharmaceuticals, San Diego, CA, USA
    Vasc Health Risk Manag 8:621-9. 2012

Collaborators

Detail Information

Publications1

  1. pmc Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
    Elaine Chiquette
    Amylin Pharmaceuticals, San Diego, CA, USA
    Vasc Health Risk Manag 8:621-9. 2012
    ..Exenatide, a glucagon-like peptide 1 receptor agonist, improved glycemic control, obesity, hypertension, and dyslipidemia in patients with type 2 diabetes in clinical trials...